Hypothermic treatment alters the metabolic profile of newborns, mimicking or masking an inherited metabolic disorder

Hypothermic treatment, initiated within the first six hours of life, is currently the main treatment capable of reducing brain damage in newborns with asphyxia and moderate or severe hypoxic-ischaemic encephalopathy. However, it is not yet clear how the treatment alters the newborn’s metabolic profile, nor whether such changes might mask or mimic a metabolic disorder, leading to false positives or false negatives in screening for inherited metabolic disorders. The present study therefore assessed changes in the metabolites routinely analysed in the Italian neonatal screening programme. A comparative analysis was conducted between full-term newborns with asphyxia/ hypoxic-ischaemic encephalopathy who underwent hypothermic treatment and a control group, through tandem mass spectrometry analysis. Treatment resulted in a number of changes being observed, including a decrease in glutamate, an increase in glycine, a reduction in certain short- and long-chain carnitines, and an increase in lysophosphatidylcholines. These findings suggest that hypothermic treatment may significantly alter the metabolic profile of the newborns. Consequently, the findings of our research have indicated that it is recommended to take dried blood spot samples at the conclusion of hypothermic treatment, with the aim of reducing the risk that the treatment may affect the interpretation of screening for inherited metabolic disorders. However, further studies are required to ascertain the usefulness and necessity of incorporating this second test into newborn screening protocols.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-16
DOI
https://doi.org/10.1038/s41598-026-78341-4
Primary Topic
Metabolism and Genetic Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Hypothermic treatment alters the metabolic profile of newborns, mimicking or masking an inherited metabolic disorder

Concetta Meli, Marianna Messina, Martino Ruggieri, Federica Raudino
2 links
Scientific Reports
Metabolism and Genetic Disorders
article

Hypothermic treatment alters the metabolic profile of newborns, mimicking or masking an inherited metabolic disorder

Concetta Meli, Marianna Messina, Martino Ruggieri, Federica Raudino
article en

Abstract

Hypothermic treatment, initiated within the first six hours of life, is currently the main treatment capable of reducing brain damage in newborns with asphyxia and moderate or severe hypoxic-ischaemic encephalopathy. However, it is not yet clear how the treatment alters the newborn’s metabolic profile, nor whether such changes might mask or mimic a metabolic disorder, leading to false positives or false negatives in screening for inherited metabolic disorders. The present study therefore assessed changes in the metabolites routinely analysed in the Italian neonatal screening programme. A comparative analysis was conducted between full-term newborns with asphyxia/ hypoxic-ischaemic encephalopathy who underwent hypothermic treatment and a control group, through tandem mass spectrometry analysis. Treatment resulted in a number of changes being observed, including a decrease in glutamate, an increase in glycine, a reduction in certain short- and long-chain carnitines, and an increase in lysophosphatidylcholines. These findings suggest that hypothermic treatment may significantly alter the metabolic profile of the newborns. Consequently, the findings of our research have indicated that it is recommended to take dried blood spot samples at the conclusion of hypothermic treatment, with the aim of reducing the risk that the treatment may affect the interpretation of screening for inherited metabolic disorders. However, further studies are required to ascertain the usefulness and necessity of incorporating this second test into newborn screening protocols.

Scientific Reports
University of Catania (IT), Policlinico Universitario di Catania (IT), Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco" (IT)
Good health and well-being
Metabolism and Genetic Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon